Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Opinion on Drug Discovery|February 8, 2013
Advances in the design of ITK inhibitorsJean-Damien Charrier, Ronald M A KnegtelMolecular Informatics|July 29, 2016
A Role for Hydration in Interleukin-2 Inducible T Cell Kinase (Itk) SelectivityRonald M A Knegtel, Daniel D RobinsonPharmaceutical Research|November 20, 2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compoundsLuca Settimo, Krista Bellman, Ronald M A KnegtelBiochimica Et Biophysica Acta|June 19, 2007
Site-directed mutagenesis of glutamate 317 of bovine alpha-1,3Galactosyltransferase and its effect on enzyme activity: implications for reaction mechanismPatricia Molina, Ronald M A Knegtel, Bruce A MacherGlycobiology|October 1, 2004
Mutation of amino acids in the alpha 1,3-fucosyltransferase motif affects enzyme activity and Km for donor and acceptor substratesFranziska Jost, Theodora de Vries, Ronald M A Knegtel, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2004
Water-soluble molecular capsules: self-assembly and binding propertiesFrancesca Corbellini, Ronald M A Knegtel, Peter D J Grootenhuis, et al.The Journal of Biological Chemistry|September 19, 2002
Crystal structure of aurora-2, an oncogenic serine/threonine kinaseGraham M T Cheetham, Ronald M A Knegtel, Joyce T Coll, et al.Journal of Medicinal Chemistry|March 12, 2011
Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitorsJean-Damien Charrier, Andrew Miller, David P Kay, et al.ACS Medicinal Chemistry Letters|August 17, 2019
Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune EncephalomyelitisPhilip N Collier, Heather C Twin, Ronald M A Knegtel, et al.Journal of Medicinal Chemistry|March 19, 2011
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agentsJean-Damien Charrier, Steven J Durrant, Julian M C Golec, et al.Pageof 1